Stockreport

Lexicon Pharmaceuticals stock to be halted Thursday as FDA committee reviews diabetes treatment [MarketWatch]

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors
PDF Lexicon Pharmaceuticals stock to be halted Thursday as FDA committee reviews diabetes treatment Lexicon Pharmaceuticals Inc. stock LXRX, +1.32% will be halted from tra [Read more]